FIELD: biotechnologies.
SUBSTANCE: invention refers to new positively charged NSAIA prodrugs of a common formula (1, 2a, 2b, 2c or 2d) of "1, 2a, 2b, 2c or 2d structure"
Structure 1, Structure 2a,
Structure 2b, Structure 2c, Structure 2d. Values of R, R1, R2, R3, R4, R5, Ary, X radicals are presented in Claims 1,2.
EFFECT: increasing agent penetration speed.
22 cl, 14 tbl
Authors
Dates
2014-03-10—Published
2007-06-04—Filed